CPC Main Group
A61P 9/00 Drugs for disorders of the cardiovascular system
7 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61P 9/02 Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A61P 9/04 Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A61P 9/06 Antiarrhythmics
- A61P 9/08 Vasodilators for multiple indications
- A61P 9/10 for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12 Antihypertensives
- A61P 9/14 Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513